NOVO.B.DK

249.05

+1.47%↑

GMAB.DK

1,779.5

-0.64%↓

HLUNB.DK

38.16

-0.21%↓

ZEAL.DK

369.8

-0.7%↓

AMBUB.DK

76.8

-2.35%↓

NOVO.B.DK

249.05

+1.47%↑

GMAB.DK

1,779.5

-0.64%↓

HLUNB.DK

38.16

-0.21%↓

ZEAL.DK

369.8

-0.7%↓

AMBUB.DK

76.8

-2.35%↓

NOVO.B.DK

249.05

+1.47%↑

GMAB.DK

1,779.5

-0.64%↓

HLUNB.DK

38.16

-0.21%↓

ZEAL.DK

369.8

-0.7%↓

AMBUB.DK

76.8

-2.35%↓

NOVO.B.DK

249.05

+1.47%↑

GMAB.DK

1,779.5

-0.64%↓

HLUNB.DK

38.16

-0.21%↓

ZEAL.DK

369.8

-0.7%↓

AMBUB.DK

76.8

-2.35%↓

NOVO.B.DK

249.05

+1.47%↑

GMAB.DK

1,779.5

-0.64%↓

HLUNB.DK

38.16

-0.21%↓

ZEAL.DK

369.8

-0.7%↓

AMBUB.DK

76.8

-2.35%↓

Search

Coloplast A-S (Class B)

Închisă

463.9 -0.69

Rezumat

Modificarea prețului

24h

Curent

Minim

458.6

Maxim

467.1

Indicatori cheie

By Trading Economics

Venit

522M

1.4B

Vânzări

83M

7B

P/E

Medie Sector

27.175

66.845

EPS

6.32

Randament dividend

4.74

Marjă de profit

19.835

Angajați

16,983

EBITDA

309M

2.3B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

4.74%

2.25%

Următoarele câștiguri

12 mai 2026

Data viitoare de dividende

20 mai 2026

Următoarea dată ex-dividende

18 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-10B

108B

Deschiderea anterioară

464.59

Închiderea anterioară

463.9

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

4 mar. 2026, 23:39 UTC

Acțiuni populare

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

4 mar. 2026, 23:20 UTC

Câștiguri

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

4 mar. 2026, 21:43 UTC

Câștiguri

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

4 mar. 2026, 23:48 UTC

Market Talk

Nikkei May Rise After Recent Selloffs -- Market Talk

4 mar. 2026, 23:33 UTC

Market Talk
Evenimente importante

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

4 mar. 2026, 23:24 UTC

Market Talk

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

4 mar. 2026, 22:30 UTC

Câștiguri

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

4 mar. 2026, 22:30 UTC

Câștiguri

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

4 mar. 2026, 22:30 UTC

Câștiguri

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

4 mar. 2026, 22:13 UTC

Câștiguri

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

4 mar. 2026, 22:13 UTC

Câștiguri

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

4 mar. 2026, 22:13 UTC

Câștiguri

Vermilion Energy 4Q EPS C$2.86 >VET

4 mar. 2026, 22:04 UTC

Market Talk

RBA Slipping Behind The Curve On Rates -- Market Talk

4 mar. 2026, 21:53 UTC

Câștiguri

Lithium Americas 4Q Rev $66.8M >LAC

4 mar. 2026, 21:53 UTC

Câștiguri

Lithium Americas 4Q Loss/Shr 52c >LAC

4 mar. 2026, 21:52 UTC

Câștiguri

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mar. 2026, 21:50 UTC

Câștiguri

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

4 mar. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4 mar. 2026, 21:48 UTC

Câștiguri

Webull 4Q Rev $165.2M >BULL

4 mar. 2026, 21:48 UTC

Câștiguri

Webull 4Q EPS 1c >BULL

4 mar. 2026, 21:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4 mar. 2026, 21:45 UTC

Market Talk

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

4 mar. 2026, 21:40 UTC

Câștiguri

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mar. 2026, 21:36 UTC

Evenimente importante

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

4 mar. 2026, 21:27 UTC

Câștiguri

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mar. 2026, 21:17 UTC

Market Talk

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

4 mar. 2026, 21:16 UTC

Câștiguri

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

4 mar. 2026, 21:15 UTC

Câștiguri

Broadcom 1Q EPS $1.50 >AVGO

4 mar. 2026, 21:15 UTC

Câștiguri

Broadcom 1Q Net $7.35B >AVGO

4 mar. 2026, 21:15 UTC

Câștiguri

Broadcom 1Q Rev $19.31B >AVGO

Comparație

Modificare preț

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat